Home › Atherosclerosis › Ohio
Atherosclerosis clinical trials in Ohio
8 studies for Atherosclerosis are looking for participants at sites in Ohio.
Cities in Ohio
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Cleveland, Beachwood
- Aultman Hospital, Cardiovascular Consultants, Inc, Canton
- Velocity Clinical Research - Auburn, Cincinnati
- and 2 more
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Oct 5, 2026 · NCT07037433A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
- Velocity Clinical Research, Cleveland, Cleveland
- Centricity Research Columbus Ohio Multispecialty, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- The Christ Hospital, Cincinnati
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- HNC Dialysis, Ltd., Columbus
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Cincinnati
- Research Site, Columbus
- Research Site, Lima
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- NexGen Research, Lima
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.